Cargando…
Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
Autores principales: | Reuken, Philipp A., Torres, Dorian, Baier, Michael, Löffler, Bettina, Lübbert, Christoph, Lippmann, Norman, Stallmach, Andreas, Bruns, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305072/ https://www.ncbi.nlm.nih.gov/pubmed/28192501 http://dx.doi.org/10.1371/journal.pone.0172373 |
Ejemplares similares
-
Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
por: Reuken, Philipp A., et al.
Publicado: (2017) -
Development and validation of a simple and robust model to predict 30-day mortality in patients with Clostridioides difficile-associated enterocolitis
por: Katzer, Katrin Claudia, et al.
Publicado: (2020) -
Between fear and courage: Attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic
por: Reuken, Philipp A., et al.
Publicado: (2020) -
Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study
por: Franz, Anika, et al.
Publicado: (2023) -
Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis
por: Horn, Paul, et al.
Publicado: (2018)